Fernández-Aceñero Ma Jesús, Estrada Muñoz Lourdes, Sastre Varela Javier, Corona Sánchez Juan Antonio, Díaz Del Arco Cristina, García Paredes Beatriz, Córdoba Largo Sofía, Del Puerto Nevado Laura
Department of Surgical Pathology, Hospital Clínico San Carlos and Oncology, Madrid, Spain.
Department of Oncology, Hospital Clínico San Carlos and Oncology, Madrid, Spain.
J Gastrointest Oncol. 2017 Feb;8(1):49-54. doi: 10.21037/jgo.2017.01.02.
Neoadjuvant chemoradiation therapy (CRT) is an important management strategy in rectal carcinoma. Different systems grading response have shown varying prognostic influence.
To analyze the prognostic influence of pathological response in a series of 183 patients with rectal carcinoma receiving neoadjuvant therapy. To determine the prognostic significance of the histopathological patterns of response.
A total of 183 patients from two hospitals. The concordance rate between pathologists was good. In total, 18% of the patients showed grade 0 (complete response), 31.7% grade 1, 19.2% grade 2 and 31.1% grade 3 regression. T down-staging was found in 51.9% of the cases. 46 patients recurred and 18 died of disease (median follow-up time: 39 months). We found a statistically significant association between pathological response and pT stage and down-staging. Inflammatory reaction in the tumor bed was significantly associated to regression and prognosis. Cox's multivariate analysis of survival revealed that down-staging and presence of mucin pools in the tumor bed behaved as significant predictors of recurrence and regression grade and mucin pools as significant predictors of survival.
Pathological response is an important surrogate marker of prognosis in some large series, but results are varying. There are many systems to grade regression and this makes it difficult to compare the results by different groups. It is important to report the specific pattern of response, for some of them may have prognostic relevance. We feel there is an urgent need to develop standarized protocols and employ a universal regression scheme if we intend to use this factor to guide therapy.
新辅助放化疗(CRT)是直肠癌的重要治疗策略。不同的系统对反应进行分级,显示出不同的预后影响。
分析183例接受新辅助治疗的直肠癌患者的病理反应的预后影响。确定反应的组织病理学模式的预后意义。
来自两家医院的183例患者。病理学家之间的一致性良好。总共有18%的患者显示0级(完全缓解),31.7%为1级,19.2%为2级,31.1%为3级消退。51.9%的病例发现T分期降低。46例复发,18例死于疾病(中位随访时间:39个月)。我们发现病理反应与pT分期和分期降低之间存在统计学上的显著关联。肿瘤床的炎症反应与消退和预后显著相关。Cox生存多因素分析显示,分期降低和肿瘤床中黏液池的存在是复发和消退分级的重要预测因素,黏液池是生存的重要预测因素。
在一些大型系列研究中,病理反应是预后的重要替代指标,但结果各不相同。有许多系统对消退进行分级,这使得不同组之间难以比较结果。报告具体的反应模式很重要,因为其中一些可能具有预后相关性。我们认为,如果我们打算利用这个因素来指导治疗,迫切需要制定标准化方案并采用通用的消退方案。